| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |